{
    "nct_id": "NCT04668833",
    "official_title": "Phase I Study of Autologous Lymphocyte Infusions After Radiation Therapy to Mitigate Radiation Induced Lymphopenia and Enhance Immune Reconstitution in Patients With Solid Tumor Malignancies",
    "inclusion_criteria": "Histologically or cytologically documented NSCLC or esophageal cancers Stage II-IVA disease where definitive chemoradiation is the standard of care Age 18\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "Prior radiotherapy to the chest Life expectancy<6 months Any systemic therapy, aside from standard of care immunotherapy, that is planned to be administered prior to 6 weeks after ALI. Pregnancy",
    "miscellaneous_criteria": ""
}